Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-07-10
2008-07-08
Wang, Shengjun (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S396000
Reexamination Certificate
active
07396848
ABSTRACT:
A neurotrophin production/secretion promoting agent which comprises an azole derivative of the formula:wherein R1represents a halogen atom, a heterocyclic group which may optionally be substituted, a hydroxy group which may optionally be substituted, a thiol group which may optionally be substituted, or an amino group which may optionally be substituted; A represents an acyl group which may optionally be substituted, a heterocyclic group which may optionally be substituted, a hydroxy group which may optionally be substituted, or a carboxyl group which may optionally be esterified or amidated; B represents an aromatic group which may optionally be substituted; X represents oxygen atom, sulfur atom, or nitrogen atom which may optionally be substituted; and Y represents a divalent hydrocarbon group or heterocyclic group, or a salt thereof; which is useful as an agent for preventing or treating neuropathy.
REFERENCES:
patent: 3575991 (1971-04-01), Kim
patent: 6605629 (2003-08-01), Momose et al.
patent: 0 033 617 (1981-08-01), None
patent: 0 555 149 (1993-08-01), None
patent: 0 906 755 (1999-04-01), None
patent: 1 574 583 (1980-09-01), None
patent: 62-178590 (1987-08-01), None
patent: 62-234018 (1987-10-01), None
patent: 7-242663 (1995-09-01), None
patent: WO-95/01979 (1995-01-01), None
patent: WO 97 36882 (1997-10-01), None
patent: WO 99/16460 (1999-04-01), None
patent: WO 00 01679 (2000-01-01), None
patent: WO 01 19806 (2001-03-01), None
Pillay et al. “Molecular mechanisms, Emerging Etiological insights and model to test potential therapeutical interventions in Alzheimer's disease,” Current Alzheimer Research, 2004, vol. 1, No. 4, pp. 295-306.
Gieldanowski,Jerzy, et al. “Pharmacological Activity in the Group of New Substituted Thiazoloacetic and Thiazinocarboxyl Acid Derivatives” Archivum Immunologiae et Thereapiae Experiementalis 26:921-929 (1978).
Brown, Kevan, et al. “Nonsteroidal Antiinflammatory Agents. 1. 2,4-Diphenylthiazole-5-acetic Acid and Related Compounds” Journal of Medicinal Chemistry 17(11): 1177-1181(1974).
Sharma, Pawan K., et al. “Synthesis and Antiinflammatory Activity of Some 1,4-Dihydro-3-methyl-1-(2-thiazolyl)pyrazolo[4,3-c][1,2]benzothiazine 5,5-Diozides” Bull. Chem. Soc. Jpn. 66(12): 3843-3846 (1993).
Sawhney, S.N., et al. “Synthesis & Antiinflammatory Activity of Some 5-Thiazoleacetic Acids” Indian Journal of Chemistry 22B: 1044-1049(1983).
Jakobiec, Tadeusz, et al. “Studies on the Derivatives of 2-Amino-4-P-Chlorophenylthiazole-5-Acetic Acid” Archivum Immunologiae et Thereapiae Experiementalis, 27: 777-794 (1979).
Hirai, Kentaro, et al. “Synthesis of 2-Disubstituted-amino-4-arylthiazol-5-ylalkanoic Acids” Chem. Pharm. Bull. 25(9):2292-2299(1977).
Sharma P K et al. “Potent antiinflammatory 3-thiazole-4(5)-acetic acids of 1,2-benzisothiazole” Biorganic & Medicinal Chem. Let., Gb, Oxford (1997) 7(18), 2427-2430.
Kawakita, T et al., “Preparation of benzoxazine derivatives as phospholipase A2 and interleukin 1 inhibitors” CHEMABS Database accession No. 124:117333—JP07 242663 A, Sep. 19, 1995.
Gieldanowski, Jerzy et al: “Pharmacological activity in the group of new substituted thiazoloacetic and thiazinocardboxyl acid derivatives” CHEMABS Database accession No. 91:68296,—Arch. Immunol. Ther. Exp. (1978) 26(1-6), 921-9.
Hirai, Kentaro et al., “2-Dialkylamino-4aryl-5-thiazoleacetic acids” CHEMABS Database accession No. 86:89798,—JP 51 088964 A, Aug. 4, 1976.
Brown, Kevan, et al. “Nonsteroidal antiinflammatory agents.1. 2,4-Diphenylthiazole-5-acetic acid and related compounds” CHEMABS Database accession No. 82:38473,—J. Med. Chem. (1974) 17(11), 1177-1181.
Sharma, Pawan K. et al, “Synthesis and antiinflammatory activity of some 1,4-dihydro-3-methyl-1-(2-thiazolyl)pyrazolo'4,3-c(1,2) benzothiazine 5,5-dioxides” CHEMABS Database accession No. 121:9292,—Chem. Soc. JPN (1993) 66(12), 3842-6.
Sawhney, S.N. et al., “Synthesis and antiinflammatory activity of some 5-thiazoleacetic acids” CHEMABS Database accession No. 100:139014,—Indiana J. Chem., Sect. B (1983) 22B(10), 1044-9.
Stankiewicz, Julian et al., “Studies on derivatives of 2-amino-4-(p-chlorophenyl)thiazole-5-acetic acid” CHEMABS Database accession No. 98:53756,—Arch. Immunol. ther. Exp. (1981) 29(6), 827-33.
Jacobiec, Tadeusz et al., “Studies on the derivatives of 2-amino-4-p-chlorophenylthiazole-5-acetic acid” CHEMABS Database accession No. 93:36820,—Arch Immunol. Ther. Exp. (1979) 27(6), 777-94.
Hirai, Kentaro et al., “Studies on heterocyclic cation systems. XI. Synthesis of 2-disubstituted-amino-4-arylthiazol-5-ylal kanoic acids” CHEMABS database accession No. 88:50706,—Chem. Pharm. Bull. (1977) 25(9), 2292-9.
Kondo Sei,—JP 08 175992 A, Jul. 9, 1996, abstract in Patent Abstracts of Japn. vol. 1996, No. 11, Nov. 29, 1996.
Momose Yu
Murase Katsuhito
Butler Gregory B.
Conlin David G.
Takeda Pharmaceutical Company Limited
Wang Shengjun
LandOfFree
Neurotrophin production/secretion promoting agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neurotrophin production/secretion promoting agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neurotrophin production/secretion promoting agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3967149